# ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma

> **NCT05148598** · PHASE3 · UNKNOWN · sponsor: **Paracrine, INC.** · enrollment: 174 (estimated)

## Conditions studied

- Scleroderma, Diffuse

## Interventions

- **DEVICE:** ADRCs
- **OTHER:** Standard Care
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05148598
- **Lead sponsor:** Paracrine, INC.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-28
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05148598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05148598, "ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05148598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*